CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: oxazinoquinoline
Accession: CHEBI:53665
browse the term
Definition: Any organic heterotricyclic compound based on a skeleton comprised of an oxazine ring fused onto a quinoline system.
Synonyms: related_synonym: oxazinoquinolines
G
Abcc3
ATP binding cassette subfamily C member 3
decreases activity
ISO
Levofloxacin results in decreased activity of ABCC3 protein
CTD
PMID:39023798
NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,793,583...79,839,494
G
Abcc4
ATP binding cassette subfamily C member 4
decreases activity
ISO
Levofloxacin results in decreased activity of ABCC4 protein
CTD
PMID:39023798
NCBI chr15:101,948,387...102,182,912
Ensembl chr15:101,949,433...102,181,375
G
Abhd1
abhydrolase domain containing 1
decreases expression
EXP
Levofloxacin results in decreased expression of ABHD1 mRNA
CTD
PMID:24136188
NCBI chr 6:31,142,476...31,147,464
Ensembl chr 6:31,142,476...31,147,464
G
Acsf2
acyl-CoA synthetase family member 2
decreases expression
EXP
Levofloxacin results in decreased expression of ACSF2 mRNA
CTD
PMID:24136188
NCBI chr10:80,001,389...80,043,796
Ensembl chr10:80,001,389...80,045,050
G
Acsl5
acyl-CoA synthetase long-chain family member 5
decreases expression
EXP
Levofloxacin results in decreased expression of ACSL5 mRNA
CTD
PMID:24136188
NCBI chr 1:264,294,851...264,341,943
Ensembl chr 1:264,294,864...264,341,943
G
Actg1
actin, gamma 1
decreases expression
EXP
Levofloxacin results in decreased expression of ACTG1 mRNA
CTD
PMID:24136188
NCBI chr10:106,118,106...106,120,951
Ensembl chr10:106,118,108...106,120,951
G
Acy1
aminoacylase 1
decreases expression
EXP
Levofloxacin results in decreased expression of ACY1 mRNA
CTD
PMID:24136188
NCBI chr 8:115,951,068...115,956,471
Ensembl chr 8:115,951,068...115,956,405
G
Afp
alpha-fetoprotein
decreases expression
EXP
Levofloxacin results in decreased expression of AFP mRNA
CTD
PMID:24136188
NCBI chr14:17,857,584...17,875,645
Ensembl chr14:17,857,584...17,875,649
G
Aldh1b1
aldehyde dehydrogenase 1 family, member B1
decreases expression
EXP
Levofloxacin results in decreased expression of ALDH1B1 mRNA
CTD
PMID:24136188
NCBI chr 5:64,859,000...64,864,008
Ensembl chr 5:64,858,934...64,864,365
G
Angptl6
angiopoietin-like 6
increases expression
EXP
Levofloxacin results in increased expression of ANGPTL6 mRNA
CTD
PMID:24136188
NCBI chr 8:27,689,804...27,696,172
Ensembl chr 8:27,689,806...27,696,111
G
Anxa1
annexin A1
decreases expression
EXP
Levofloxacin results in decreased expression of ANXA1 mRNA
CTD
PMID:24136188
NCBI chr 1:227,287,713...227,306,739
Ensembl chr 1:227,287,717...227,306,831
G
Anxa2
annexin A2
decreases expression
EXP
Levofloxacin results in decreased expression of ANXA2 mRNA
CTD
PMID:24136188
NCBI chr 8:78,986,252...79,022,638
Ensembl chr 8:78,986,242...79,022,631
G
Ap1s1
adaptor related protein complex 1 subunit sigma 1
decreases expression
EXP
Levofloxacin results in decreased expression of AP1S1 mRNA
CTD
PMID:24136188
NCBI chr12:25,261,958...25,272,483
Ensembl chr12:25,262,036...25,272,483
G
Arl4a
ARF like GTPase 4A
increases expression
EXP
Levofloxacin results in increased expression of ARL4A mRNA
CTD
PMID:24136188
NCBI chr 6:62,809,287...62,811,297
Ensembl chr 6:62,804,548...62,820,760
G
Aspa
aspartoacylase
decreases expression
EXP
Levofloxacin results in decreased expression of ASPA mRNA
CTD
PMID:24136188
NCBI chr10:58,390,204...58,443,790
Ensembl chr10:58,379,410...58,443,769
G
Atg2b
autophagy related 2B
increases expression
EXP
Levofloxacin results in increased expression of ATG2B mRNA
CTD
PMID:24136188
NCBI chr 6:130,286,979...130,357,109
Ensembl chr 6:130,286,986...130,357,109
G
Atp6v0e2
ATPase, H+ transporting V0 subunit e2
decreases expression
EXP
Levofloxacin results in decreased expression of ATP6V0E2 mRNA
CTD
PMID:24136188
NCBI chr 4:78,815,771...78,818,919
Ensembl chr 4:78,813,129...78,819,680
G
Birc2
baculoviral IAP repeat-containing 2
multiple interactions
ISO
[Levofloxacin co-treated with TNF protein] results in increased expression of BIRC2 mRNA
CTD
PMID:32035082
NCBI chr 8:13,253,697...13,273,672
Ensembl chr 8:13,253,706...13,271,911
G
Bmp6
bone morphogenetic protein 6
decreases expression
ISO
Levofloxacin results in decreased expression of BMP6 mRNA
CTD
PMID:32816093
NCBI chr17:26,523,704...26,785,558
Ensembl chr17:26,523,704...26,675,261
G
Bst2
bone marrow stromal cell antigen 2
decreases expression
EXP
Levofloxacin results in decreased expression of BST2 mRNA
CTD
PMID:24136188
NCBI chr16:18,250,593...18,254,967
Ensembl chr16:18,251,847...18,254,967
G
Btg1
BTG anti-proliferation factor 1
increases expression
EXP
Levofloxacin results in increased expression of BTG1 mRNA
CTD
PMID:24136188
NCBI chr 7:33,228,149...33,230,406
Ensembl chr 7:33,227,833...33,230,406
G
C2cd2
C2 calcium-dependent domain containing 2
decreases expression
EXP
Levofloxacin results in decreased expression of C2CD2 mRNA
CTD
PMID:24136188
NCBI chr11:50,694,680...50,759,096
Ensembl chr11:50,694,563...50,759,016
G
C4b
complement C4B
increases expression
EXP
Levofloxacin results in increased expression of C4B mRNA
CTD
PMID:24136188
NCBI chr20:4,201,979...4,216,292
Ensembl chr20:4,201,961...4,216,289
G
C5
complement C5
increases expression
EXP
Levofloxacin results in increased expression of C5 mRNA
CTD
PMID:24136188
NCBI chr 3:38,668,174...38,759,468
Ensembl chr 3:38,668,174...38,759,468
G
C5l1
complement C5 like 1
increases expression
EXP
Levofloxacin results in increased expression of C5L1 mRNA
CTD
PMID:24136188
NCBI chr 3:38,799,165...38,818,443
Ensembl chr 3:38,799,731...38,817,527
G
C8h11orf54
similar to human chromosome 11 open reading frame 54
decreases expression
EXP
Levofloxacin results in decreased expression of C8H11ORF54 mRNA
CTD
PMID:24136188
NCBI chr 8:20,405,240...20,427,811
Ensembl chr 8:20,405,241...20,427,811
G
C8h11orf65
similar to human chromosome 11 open reading frame 65
increases expression
EXP
Levofloxacin results in increased expression of C8H11ORF65 mRNA
CTD
PMID:24136188
NCBI chr 8:62,692,123...62,720,951
Ensembl chr 8:62,692,568...62,720,946
G
Ca14
carbonic anhydrase 14
decreases expression
EXP
Levofloxacin results in decreased expression of CAR14 mRNA
CTD
PMID:24136188
NCBI chr 2:186,131,196...186,138,164
Ensembl chr 2:186,129,341...186,138,863
G
Casp3
caspase 3
multiple interactions
ISO
[Levofloxacin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein
CTD
PMID:30876886
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
G
Ccdc6
coiled-coil domain containing 6
increases expression
EXP
Levofloxacin results in increased expression of CCDC6 mRNA
CTD
PMID:24136188
NCBI chr20:18,431,243...18,527,227
Ensembl chr20:18,431,243...18,527,227
G
Ccdc80
coiled-coil domain containing 80
decreases expression
EXP
Levofloxacin results in decreased expression of CCDC80 mRNA
CTD
PMID:24136188
NCBI chr11:69,191,188...69,224,844
Ensembl chr11:69,191,189...69,224,844
G
Cd302
CD302 molecule
increases expression
EXP
Levofloxacin results in increased expression of CD302 mRNA
CTD
PMID:24136188
NCBI chr 3:65,131,017...65,164,737
Ensembl chr 3:65,113,102...65,164,737
G
Cdc42ep4
CDC42 effector protein 4
increases expression
EXP
Levofloxacin results in increased expression of CDC42EP4 mRNA
CTD
PMID:24136188
NCBI chr10:99,271,750...99,298,551
Ensembl chr10:99,267,540...99,300,168
G
Cdk1
cyclin-dependent kinase 1
decreases expression
EXP
Levofloxacin results in decreased expression of CDK1 mRNA
CTD
PMID:24136188
NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455
G
Cdkn3
cyclin-dependent kinase inhibitor 3
decreases expression
EXP
Levofloxacin results in decreased expression of CDKN3 mRNA
CTD
PMID:24136188
NCBI chr15:22,502,299...22,513,725
Ensembl chr15:22,502,382...22,513,722
G
Cebpb
CCAAT/enhancer binding protein beta
increases expression
EXP
Levofloxacin results in increased expression of CEBPB mRNA
CTD
PMID:24136188
NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:176,816,859...176,838,072
G
Cfhr1
complement factor H-related 1
increases expression
EXP
Levofloxacin results in increased expression of CFHR1 mRNA
CTD
PMID:24136188
NCBI chr13:53,946,298...53,961,282
Ensembl chr13:53,919,927...53,961,303
G
Cgn
cingulin
decreases expression
EXP
Levofloxacin results in decreased expression of CGN mRNA
CTD
PMID:24136188
NCBI chr 2:184,997,425...185,024,785
Ensembl chr 2:184,997,425...185,023,635
G
Chpt1
choline phosphotransferase 1
increases expression
EXP
Levofloxacin results in increased expression of CHPT1 mRNA
CTD
PMID:24136188
NCBI chr 7:24,753,880...24,802,529
Ensembl chr 7:24,750,343...24,802,521
G
Cks2
CDC28 protein kinase regulatory subunit 2
decreases expression
EXP
Levofloxacin results in decreased expression of CKS2 mRNA
CTD
PMID:24136188
NCBI chr17:13,722,360...13,727,519
Ensembl chr17:13,722,361...13,727,519
G
Clec14a
C-type lectin domain containing 14A
increases expression
EXP
Levofloxacin results in increased expression of CLEC14A mRNA
CTD
PMID:24136188
NCBI chr 6:81,616,414...81,619,556
Ensembl chr 6:81,612,953...81,619,614
G
Cmbl
carboxymethylenebutenolidase homolog
decreases expression
EXP
Levofloxacin results in decreased expression of CMBL mRNA
CTD
PMID:24136188
NCBI chr 2:84,280,128...84,301,878
Ensembl chr 2:84,242,512...84,301,880
G
Cpt1a
carnitine palmitoyltransferase 1A
increases expression
EXP
Levofloxacin results in increased expression of CPT1A mRNA
CTD
PMID:24136188
NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:209,993,875...210,056,326
G
Cyp27a1
cytochrome P450, family 27, subfamily a, polypeptide 1
increases expression
EXP
Levofloxacin results in increased expression of CYP27A1 mRNA
CTD
PMID:24136188
NCBI chr 9:83,712,402...83,743,222
Ensembl chr 9:83,713,293...83,743,215
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
decreases activity
ISO
Levofloxacin results in decreased activity of CYP3A4 protein
CTD
PMID:39023798
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
G
Cyp4b1
cytochrome P450, family 4, subfamily b, polypeptide 1
increases expression
EXP
Levofloxacin results in increased expression of CYP4B1 mRNA
CTD
PMID:24136188
NCBI chr 5:134,375,807...134,413,635
Ensembl chr 5:134,375,807...134,393,116
G
Cyp51
cytochrome P450, family 51
increases expression
EXP
Levofloxacin results in increased expression of CYP51 mRNA
CTD
PMID:24136188
NCBI chr 4:30,991,693...31,010,147
Ensembl chr 4:30,991,613...31,010,450
G
Ddc
dopa decarboxylase
decreases expression
EXP
Levofloxacin results in decreased expression of DDC mRNA
CTD
PMID:24136188
NCBI chr14:90,592,304...90,682,830
Ensembl chr14:90,592,304...90,682,806
G
Ddhd1
DDHD domain containing 1
decreases expression
EXP
Levofloxacin results in decreased expression of DDHD1 mRNA
CTD
PMID:24136188
NCBI chr15:21,304,053...21,370,608
Ensembl chr15:21,303,826...21,370,608
G
Dhfr
dihydrofolate reductase
decreases activity
ISO
Levofloxacin results in decreased activity of DHFR protein
CTD
PMID:25418905
NCBI chr 2:25,320,895...25,346,004
G
Dnajc9
DnaJ heat shock protein family (Hsp40) member C9
decreases expression
EXP
Levofloxacin results in decreased expression of DNAJC9 mRNA
CTD
PMID:24136188
NCBI chr15:3,970,843...4,003,009
Ensembl chr15:3,970,114...3,977,304
G
Dnph1
2'-deoxynucleoside 5'-phosphate N-hydrolase 1
decreases expression
EXP
Levofloxacin results in decreased expression of DNPH1 mRNA
CTD
PMID:24136188
NCBI chr 9:21,978,894...21,981,631
Ensembl chr 9:21,978,894...21,981,631
G
Dtymk
deoxythymidylate kinase
decreases expression
EXP
Levofloxacin results in decreased expression of DTYMK mRNA
CTD
PMID:24136188
NCBI chr 9:101,762,899...101,771,733
Ensembl chr 9:101,762,899...101,774,504
G
Dut
deoxyuridine triphosphatase
decreases expression
EXP
Levofloxacin results in decreased expression of DUT mRNA
CTD
PMID:24136188
NCBI chr 3:132,952,258...132,963,433
Ensembl chr 3:132,952,394...132,964,956
G
Edem1
ER degradation enhancing alpha-mannosidase like protein 1
increases expression
EXP
Levofloxacin results in increased expression of EDEM1 mRNA
CTD
PMID:24136188
NCBI chr 4:143,350,989...143,385,693
Ensembl chr 4:143,353,624...143,388,060
G
Elovl5
ELOVL fatty acid elongase 5
decreases expression
EXP
Levofloxacin results in decreased expression of ELOVL5 mRNA
CTD
PMID:24136188
NCBI chr 8:87,671,164...87,737,618
Ensembl chr 8:87,671,159...87,737,616
G
Enc1
ectodermal-neural cortex 1
increases expression
EXP
Levofloxacin results in increased expression of ENC1 mRNA
CTD
PMID:24136188
NCBI chr 2:30,285,274...30,297,194
Ensembl chr 2:30,283,736...30,315,721
G
Ephx1
epoxide hydrolase 1
decreases expression
EXP
Levofloxacin results in decreased expression of EPHX1 mRNA
CTD
PMID:24136188
NCBI chr13:95,246,079...95,275,852
Ensembl chr13:95,246,080...95,321,981
G
Erg28
ergosterol biosynthesis 28 homolog
increases expression
EXP
Levofloxacin results in increased expression of ERG28 mRNA
CTD
PMID:24136188
NCBI chr 6:111,205,102...111,214,068
Ensembl chr 6:111,205,103...111,214,068
G
Ergic1
endoplasmic reticulum-golgi intermediate compartment 1
decreases expression
EXP
Levofloxacin results in decreased expression of ERGIC1 mRNA
CTD
PMID:24136188
NCBI chr10:17,035,615...17,131,411
Ensembl chr10:17,035,615...17,131,376
G
Fgl1
fibrinogen-like 1
increases expression
EXP
Levofloxacin results in increased expression of FGL1 mRNA
CTD
PMID:24136188
NCBI chr16:57,824,127...57,854,413
Ensembl chr16:57,824,200...57,854,429
G
Fkbp4
FKBP prolyl isomerase 4
decreases expression
EXP
Levofloxacin results in decreased expression of FKBP4 mRNA
CTD
PMID:24136188
NCBI chr 4:163,389,464...163,397,918
Ensembl chr 4:163,389,464...163,397,918
G
Fkbp5
FKBP prolyl isomerase 5
increases expression
EXP
Levofloxacin results in increased expression of FKBP5 mRNA
CTD
PMID:24136188
NCBI chr20:6,458,931...6,577,227
Ensembl chr20:6,458,940...6,543,118
G
Flna
filamin A
decreases expression
EXP
Levofloxacin results in decreased expression of FLNA mRNA
CTD
PMID:24136188
NCBI chr X:157,159,051...157,185,559
Ensembl chr X:157,159,051...157,182,343
G
Fndc3b
fibronectin type III domain containing 3B
increases expression
EXP
Levofloxacin results in increased expression of FNDC3B mRNA
CTD
PMID:24136188
NCBI chr 2:112,240,108...112,546,113
Ensembl chr 2:112,243,202...112,546,306
G
Fzd8
frizzled class receptor 8
increases expression
EXP
Levofloxacin results in increased expression of FZD8 mRNA
CTD
PMID:24136188
NCBI chr17:62,007,849...62,015,485
Ensembl chr17:62,007,627...62,015,961
G
Gas6
growth arrest specific 6
increases expression
EXP
Levofloxacin results in increased expression of GAS6 mRNA
CTD
PMID:24136188
NCBI chr16:82,747,676...82,778,090
Ensembl chr16:82,747,345...82,778,088
G
Gclc
glutamate-cysteine ligase, catalytic subunit
decreases expression
EXP
Levofloxacin results in decreased expression of GCLC mRNA
CTD
PMID:24136188
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893
G
Glyatl2
glycine-N-acyltransferase-like 2
increases expression
EXP
Levofloxacin results in increased expression of GLYATL2 mRNA
CTD
PMID:24136188
NCBI chr 1:219,232,154...219,265,142
Ensembl chr 1:219,232,103...219,266,322
G
Gpd1
glycerol-3-phosphate dehydrogenase 1
decreases expression
EXP
Levofloxacin results in decreased expression of GPD1 mRNA
CTD
PMID:24136188
NCBI chr 7:132,722,982...132,730,373
Ensembl chr 7:132,721,915...132,730,368
G
Hacd3
3-hydroxyacyl-CoA dehydratase 3
decreases expression
EXP
Levofloxacin results in decreased expression of HACD3 mRNA
CTD
PMID:24136188
NCBI chr 8:74,396,441...74,433,700
Ensembl chr 8:74,396,442...74,433,700
G
Haus4
HAUS augmin-like complex, subunit 4
decreases expression
EXP
Levofloxacin results in decreased expression of HAUS4 mRNA
CTD
PMID:24136188
NCBI chr15:31,964,555...31,976,853
Ensembl chr15:31,964,556...31,975,941
G
Herpud1
homocysteine inducible ER protein with ubiquitin like domain 1
increases expression
EXP
Levofloxacin results in increased expression of HERPUD1 mRNA
CTD
PMID:24136188
NCBI chr19:10,604,360...10,624,168
Ensembl chr19:10,604,362...10,624,081
G
Hmgb2
high mobility group box 2
decreases expression
EXP
Levofloxacin results in decreased expression of HMGB2 mRNA
CTD
PMID:24136188
NCBI chr16:37,721,374...37,723,950
Ensembl chr16:37,721,379...37,723,860
G
Hmgn2
high mobility group nucleosomal binding domain 2
decreases expression
EXP
Levofloxacin results in decreased expression of HMGN2 mRNA
CTD
PMID:24136188
NCBI chr 5:151,475,907...151,479,361
Ensembl chr 5:151,475,909...151,479,397
G
Htatip2
HIV-1 Tat interactive protein 2
decreases expression
EXP
Levofloxacin results in decreased expression of HTATIP2 mRNA
CTD
PMID:24136188
NCBI chr 1:108,609,424...108,624,810
Ensembl chr 1:108,605,811...108,624,815
G
Icam1
intercellular adhesion molecule 1
decreases expression multiple interactions
ISO
Levofloxacin results in decreased expression of ICAM1 mRNA [Levofloxacin co-treated with TNF protein] results in increased expression of ICAM1 protein
CTD
PMID:32035082
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
G
Idi1
isopentenyl-diphosphate delta isomerase 1
increases expression
EXP
Levofloxacin results in increased expression of IDI1 mRNA
CTD
PMID:24136188
NCBI chr17:66,539,761...66,547,524
Ensembl chr17:66,539,763...66,547,524
G
Ifng
interferon gamma
increases expression
EXP
Levofloxacin results in increased expression of IFNG
CTD
PMID:24136188
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
G
Il1a
interleukin 1 alpha
increases expression
ISO
Levofloxacin results in increased expression of IL1A mRNA
CTD
PMID:32816093
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013
G
Il1b
interleukin 1 beta
multiple interactions
ISO
[Levofloxacin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein
CTD
PMID:30876886
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
G
Il24
interleukin 24
increases expression
ISO
Levofloxacin results in increased expression of IL24 mRNA
CTD
PMID:32816093
NCBI chr13:44,905,362...44,910,760
Ensembl chr13:44,905,363...44,910,760
G
Il6
interleukin 6
multiple interactions
ISO
[Levofloxacin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein
CTD
PMID:30876886
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
G
Il6r
interleukin 6 receptor
increases expression
EXP
Levofloxacin results in increased expression of IL6R mRNA
CTD
PMID:24136188
NCBI chr 2:177,582,020...177,646,705
Ensembl chr 2:177,582,164...177,645,221
G
Ip6k2
inositol hexakisphosphate kinase 2
increases expression
EXP
Levofloxacin results in increased expression of IP6K2 mRNA
CTD
PMID:24136188
NCBI chr 8:118,362,154...118,388,668
Ensembl chr 8:118,362,795...118,388,667
G
Ivns1abp
influenza virus NS1A binding protein
increases expression
EXP
Levofloxacin results in increased expression of IVNS1ABP mRNA
CTD
PMID:24136188
NCBI chr13:65,977,069...65,996,685
Ensembl chr13:65,977,045...65,997,547
G
Klf15
KLF transcription factor 15
increases expression
EXP
Levofloxacin results in increased expression of KLF15 mRNA
CTD
PMID:24136188
NCBI chr 4:124,522,652...124,535,613
Ensembl chr 4:124,522,909...124,542,373
G
Klf9
KLF transcription factor 9
increases expression
EXP
Levofloxacin results in increased expression of KLF9 mRNA
CTD
PMID:24136188
NCBI chr 1:230,126,646...230,151,641
Ensembl chr 1:230,126,646...230,151,641
G
Kpna2
karyopherin subunit alpha 2
decreases expression
EXP
Levofloxacin results in decreased expression of KPNA2 mRNA
CTD
PMID:24136188
NCBI chr10:92,433,678...92,445,841
Ensembl chr10:92,433,679...92,445,937
G
Kpnb1
karyopherin subunit beta 1
decreases expression
EXP
Levofloxacin results in decreased expression of KPNB1 mRNA
CTD
PMID:24136188
NCBI chr10:82,642,082...82,670,856
Ensembl chr10:82,642,082...82,670,856
G
Krt18
keratin 18
decreases expression
EXP
Levofloxacin results in decreased expression of KRT18 mRNA
CTD
PMID:24136188
NCBI chr 7:135,036,168...135,039,844
Ensembl chr 7:135,035,982...135,039,848 Ensembl chr10:135,035,982...135,039,848
G
Lbp
lipopolysaccharide binding protein
increases expression
EXP
Levofloxacin results in increased expression of LBP mRNA
CTD
PMID:24136188
NCBI chr 3:167,373,786...167,400,941
Ensembl chr 3:167,373,924...167,401,518
G
Lcmt1
leucine carboxyl methyltransferase 1
decreases expression
EXP
Levofloxacin results in decreased expression of LCMT1 mRNA
CTD
PMID:24136188
NCBI chr 1:187,335,173...187,391,195
Ensembl chr 1:187,327,706...187,391,516
G
Lmnb1
lamin B1
decreases expression
EXP
Levofloxacin results in decreased expression of LMNB1 mRNA
CTD
PMID:24136188
NCBI chr18:52,373,939...52,413,284
Ensembl chr18:52,373,757...52,413,283
G
Lmo7
LIM domain 7
decreases expression
EXP
Levofloxacin results in decreased expression of LMO7 mRNA
CTD
PMID:24136188
NCBI chr15:84,981,689...85,184,554
Ensembl chr15:84,981,735...85,184,551
G
Lpin1
lipin 1
increases expression
EXP
Levofloxacin results in increased expression of LPIN1 mRNA
CTD
PMID:24136188
NCBI chr 6:45,039,110...45,145,845
Ensembl chr 6:45,041,522...45,145,991
G
Lurap1l
leucine rich adaptor protein 1-like
increases expression
EXP
Levofloxacin results in increased expression of LURAP1L mRNA
CTD
PMID:24136188
NCBI chr 5:100,402,921...100,455,479
Ensembl chr 5:100,407,483...100,455,478
G
Manba
mannosidase beta
decreases expression
EXP
Levofloxacin results in decreased expression of MANBA mRNA
CTD
PMID:24136188
NCBI chr 2:226,583,968...226,676,520
Ensembl chr 2:226,583,917...226,676,517
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
multiple interactions increases expression
ISO
[TNF protein co-treated with Levofloxacin] results in increased lipidation of MAP1LC3B protein; TNF protein promotes the reaction [Levofloxacin results in increased expression of MAP1LC3B protein]
CTD
PMID:33609687
NCBI chr19:66,571,631...66,582,270
Ensembl chr19:66,574,407...66,584,358 Ensembl chr16:66,574,407...66,584,358
G
Mfsd2a
MFSD2 lysolipid transporter A, lysophospholipid
increases expression
EXP
Levofloxacin results in increased expression of MFSD2A mRNA
CTD
PMID:24136188
NCBI chr 5:140,510,933...140,525,828
Ensembl chr 5:140,510,953...140,525,916
G
Nampt
nicotinamide phosphoribosyltransferase
increases expression
EXP
Levofloxacin results in increased expression of NAMPT mRNA
CTD
PMID:24136188
NCBI chr 6:55,152,756...55,189,547
Ensembl chr 6:55,151,926...55,189,544
G
Nedd9
neural precursor cell expressed, developmentally down-regulated 9
decreases expression
EXP
Levofloxacin results in decreased expression of NEDD9 mRNA
CTD
PMID:24136188
NCBI chr17:23,495,531...23,673,780
Ensembl chr17:23,495,492...23,675,668
G
Nfe2l2
NFE2 like bZIP transcription factor 2
decreases expression
EXP
Levofloxacin results in decreased expression of NFE2L2 mRNA
CTD
PMID:24136188
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
G
Nfkbia
NFKB inhibitor alpha
increases expression multiple interactions
EXP ISO
Levofloxacin results in increased expression of NFKBIA mRNA [Levofloxacin co-treated with TNF protein] results in increased expression of NFKBIA mRNA
CTD
PMID:24136188 PMID:32035082
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
G
Nfkbiz
NFKB inhibitor zeta
increases expression
EXP
Levofloxacin results in increased expression of NFKBIZ mRNA
CTD
PMID:24136188
NCBI chr11:58,251,720...58,279,767
Ensembl chr11:58,251,721...58,279,767
G
Nrbp2
nuclear receptor binding protein 2
increases expression
EXP
Levofloxacin results in increased expression of NRBP2 mRNA
CTD
PMID:24136188
NCBI chr 7:109,679,330...109,685,656
Ensembl chr 7:109,679,330...109,685,588
G
Nudt4
nudix hydrolase 4
increases expression
EXP
Levofloxacin results in increased expression of NUDT4 mRNA
CTD
PMID:24136188
NCBI chr 7:32,074,978...32,091,491
Ensembl chr 7:32,075,002...32,091,491
G
Nupr1
nuclear protein 1, transcriptional regulator
increases expression
EXP
Levofloxacin results in increased expression of NUPR1 mRNA
CTD
PMID:24136188
NCBI chr 1:190,643,866...190,645,901
Ensembl chr 1:190,643,867...190,645,901
G
Omd
osteomodulin
increases expression
EXP
Levofloxacin results in increased expression of OMD mRNA
CTD
PMID:24136188
NCBI chr17:15,266,646...15,274,870
Ensembl chr17:15,266,646...15,274,870
G
Osbpl1a
oxysterol binding protein-like 1A
decreases expression
EXP
Levofloxacin results in decreased expression of OSBPL1A mRNA
CTD
PMID:24136188
NCBI chr18:4,178,734...4,383,511
Ensembl chr18:4,179,631...4,369,421
G
Palmd
palmdelphin
decreases expression
EXP
Levofloxacin results in decreased expression of PALMD mRNA
CTD
PMID:24136188
NCBI chr 2:207,574,413...207,626,239
Ensembl chr 2:207,574,249...207,626,239
G
Pbld1
phenazine biosynthesis-like protein domain containing 1
increases expression
EXP
Levofloxacin results in increased expression of PBLD1 mRNA
CTD
PMID:24136188
NCBI chr20:25,549,974...25,565,390
Ensembl chr20:25,549,974...25,565,226
G
Pid1
phosphotyrosine interaction domain containing 1
increases expression decreases expression
EXP ISO
Levofloxacin results in increased expression of PID1 mRNA Levofloxacin results in decreased expression of PID1 mRNA
CTD
PMID:24136188 PMID:32816093
NCBI chr 9:92,732,471...92,951,168
Ensembl chr 9:92,734,214...92,750,070
G
Pigu
phosphatidylinositol glycan anchor biosynthesis, class U
increases expression
EXP
Levofloxacin results in increased expression of PIGU mRNA
CTD
PMID:24136188
NCBI chr 3:164,245,011...164,341,444
Ensembl chr 3:164,245,011...164,341,912
G
Pla2g12a
phospholipase A2, group XIIA
increases expression
EXP
Levofloxacin results in increased expression of PLA2G12A mRNA
CTD
PMID:24136188
NCBI chr 2:221,110,722...221,126,966
Ensembl chr 2:221,110,685...221,126,964
G
Plgrkt
plasminogen receptor with a C-terminal lysine
decreases expression
EXP
Levofloxacin results in decreased expression of PLGRKT mRNA
CTD
PMID:24136188
NCBI chr 1:236,512,574...236,526,858
Ensembl chr 1:236,512,580...236,524,840
G
Plin3
perilipin 3
decreases expression
EXP
Levofloxacin results in decreased expression of PLIN3 mRNA
CTD
PMID:24136188
NCBI chr 9:1,198,336...1,210,212
Ensembl chr 9:1,198,336...1,210,231
G
Plp2
proteolipid protein 2
decreases expression
EXP
Levofloxacin results in decreased expression of PLP2 mRNA
CTD
PMID:24136188
NCBI chr X:17,506,153...17,509,552
Ensembl chr X:17,506,059...17,509,550
G
Polg2
DNA polymerase gamma 2, accessory subunit
increases expression
EXP
Levofloxacin results in increased expression of POLG2 mRNA
CTD
PMID:24136188
NCBI chr10:92,212,303...92,222,849
Ensembl chr10:92,212,304...92,222,726
G
Ppara
peroxisome proliferator activated receptor alpha
decreases expression
ISO
Levofloxacin results in decreased expression of PPARA mRNA
CTD
PMID:25689681
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714
G
Ppcs
phosphopantothenoylcysteine synthetase
increases expression
EXP
Levofloxacin results in increased expression of PPCS mRNA
CTD
PMID:24136188
NCBI chr 5:138,308,394...138,312,047
Ensembl chr 5:138,308,397...138,312,012
G
Ppif
peptidylprolyl isomerase F
decreases expression
EXP
Levofloxacin results in decreased expression of PPIF mRNA
CTD
PMID:24136188
NCBI chr16:1,264,001...1,270,722
Ensembl chr16:1,263,541...1,316,954
G
Ppp1r14a
protein phosphatase 1, regulatory (inhibitor) subunit 14A
decreases expression
EXP
Levofloxacin results in decreased expression of PPP1R14A mRNA
CTD
PMID:24136188
NCBI chr 1:93,708,269...93,718,218
Ensembl chr 1:93,708,218...93,719,147
G
Prkag2
protein kinase AMP-activated non-catalytic subunit gamma 2
decreases expression
EXP
Levofloxacin results in decreased expression of PRKAG2 mRNA
CTD
PMID:24136188
NCBI chr 4:10,744,695...10,985,939
Ensembl chr 4:10,744,588...10,985,939
G
Proser2
proline and serine rich 2
increases expression
EXP
Levofloxacin results in increased expression of PROSER2 mRNA
CTD
PMID:24136188
NCBI chr17:77,061,371...77,096,788
Ensembl chr17:77,077,727...77,095,194
G
Prxl2b
peroxiredoxin like 2B
increases expression
EXP
Levofloxacin results in increased expression of PRXL2B mRNA
CTD
PMID:24136188
NCBI chr 5:170,744,953...170,747,556
Ensembl chr 5:170,744,953...170,747,556
G
Ptgs2
prostaglandin-endoperoxide synthase 2
decreases expression
ISO
Levofloxacin results in decreased expression of PTGS2 mRNA
CTD
PMID:32816093
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
G
Pttg1
PTTG1 regulator of sister chromatid separation, securin
decreases expression
EXP
Levofloxacin results in decreased expression of PTTG1 mRNA
CTD
PMID:24136188
NCBI chr10:28,394,940...28,406,410
Ensembl chr10:28,394,814...28,406,309
G
Rapgef4
Rap guanine nucleotide exchange factor 4
increases expression
EXP
Levofloxacin results in increased expression of RAPGEF4 mRNA
CTD
PMID:24136188
NCBI chr 3:77,217,024...77,509,933
Ensembl chr 3:77,217,039...77,509,978
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
[Levofloxacin co-treated with Lipopolysaccharides] affects the localization of RELA protein
CTD
PMID:32035082
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
G
Retreg1
reticulophagy regulator 1
increases expression
EXP
Levofloxacin results in increased expression of RETREG1 mRNA
CTD
PMID:24136188
NCBI chr 2:78,045,435...78,205,316
Ensembl chr 2:78,066,031...78,225,356
G
Rmdn2
regulator of microtubule dynamics 2
decreases expression
EXP
Levofloxacin results in decreased expression of RMDN2 mRNA
CTD
PMID:24136188
NCBI chr 6:21,101,383...21,195,221
Ensembl chr 6:21,119,396...21,193,684
G
Rnd2
Rho family GTPase 2
increases expression
EXP
Levofloxacin results in increased expression of RND2 mRNA
CTD
PMID:24136188
NCBI chr10:86,899,395...86,902,992
Ensembl chr10:86,899,395...86,902,992
G
Rnf4
ring finger protein 4
decreases expression
EXP
Levofloxacin results in decreased expression of RNF4 mRNA
CTD
PMID:24136188
NCBI chr14:80,625,864...80,647,138
Ensembl chr14:80,625,866...80,647,148
G
Rnpepl1
arginyl aminopeptidase like 1
increases expression
EXP
Levofloxacin results in increased expression of RNPEPL1 mRNA
CTD
PMID:24136188
NCBI chr 9:100,921,053...100,933,748
Ensembl chr 9:100,923,856...100,933,485
G
Rpa1
replication protein A1
decreases expression
EXP
Levofloxacin results in decreased expression of RPA1 mRNA
CTD
PMID:24136188
NCBI chr10:60,647,185...60,698,279
Ensembl chr10:60,647,185...60,698,279
G
Rrm2
ribonucleotide reductase regulatory subunit M2
decreases expression
EXP
Levofloxacin results in decreased expression of RRM2 mRNA
CTD
PMID:24136188
NCBI chr 6:47,044,755...47,075,370
Ensembl chr 6:47,067,690...47,075,370
G
Rsrp1
arginine and serine rich protein 1
decreases expression
EXP
Levofloxacin results in decreased expression of RSRP1 mRNA
CTD
PMID:24136188
NCBI chr 5:152,431,448...152,435,202
Ensembl chr 5:152,431,478...152,435,126
G
Rxra
retinoid X receptor alpha
increases expression
EXP
Levofloxacin results in increased expression of RXRA mRNA
CTD
PMID:24136188
NCBI chr 3:31,387,892...31,474,415
Ensembl chr 3:31,388,223...31,474,417
G
Sc5d
sterol-C5-desaturase
increases expression
EXP
Levofloxacin results in increased expression of SC5D mRNA
CTD
PMID:24136188
NCBI chr 8:51,526,669...51,538,277
Ensembl chr 8:51,529,346...51,538,277
G
Sdc4
syndecan 4
increases expression
EXP
Levofloxacin results in increased expression of SDC4 mRNA
CTD
PMID:24136188
NCBI chr 3:173,574,239...173,592,923
Ensembl chr 3:173,574,239...173,593,670
G
Serpina11
serpin family A member 11
increases expression
EXP
Levofloxacin results in increased expression of SERPINA11 mRNA
CTD
PMID:24136188
NCBI chr 6:128,668,030...128,677,476
Ensembl chr 6:128,668,034...128,677,454
G
Serpinh1
serpin family H member 1
decreases expression
EXP
Levofloxacin results in decreased expression of SERPINH1 mRNA
CTD
PMID:24136188
NCBI chr 1:163,055,630...163,063,177
Ensembl chr 1:163,055,630...163,062,976
G
Sesn2
sestrin 2
increases expression
EXP
Levofloxacin results in increased expression of SESN2 mRNA
CTD
PMID:24136188
NCBI chr 5:149,986,304...150,005,255
Ensembl chr 5:149,986,317...150,005,255
G
Sfpq
splicing factor proline and glutamine rich
decreases expression
EXP
Levofloxacin results in decreased expression of SFPQ mRNA
CTD
PMID:24136188
NCBI chr 5:144,621,678...144,637,930
Ensembl chr 5:144,622,476...144,637,926
G
Sh3bp5
SH3-domain binding protein 5
increases expression
EXP
Levofloxacin results in increased expression of SH3BP5 mRNA
CTD
PMID:24136188
NCBI chr16:6,589,877...6,676,524
Ensembl chr16:6,589,877...6,655,211
G
Slc10a1
solute carrier family 10 member 1
decreases activity
ISO
Levofloxacin results in decreased activity of SLC10A1 protein
CTD
PMID:39023798
NCBI chr 6:106,344,319...106,357,944
Ensembl chr 6:106,344,319...106,357,944
G
Slc13a3
solute carrier family 13 member 3
increases expression
EXP
Levofloxacin results in increased expression of SLC13A3 mRNA
CTD
PMID:24136188
NCBI chr 3:174,561,174...174,623,893
Ensembl chr 3:174,561,168...174,623,895
G
Slc17a3
solute carrier family 17 member 3
decreases expression
EXP
Levofloxacin results in decreased expression of SLC17A3 mRNA
CTD
PMID:24136188
NCBI chr17:41,698,679...41,729,057
Ensembl chr17:41,698,680...41,723,329
G
Slc38a2
solute carrier family 38, member 2
increases expression
EXP
Levofloxacin results in increased expression of SLC38A2 mRNA
CTD
PMID:24136188
NCBI chr 7:129,730,450...129,742,619
Ensembl chr 7:129,730,450...129,742,619
G
Slc7a11
solute carrier family 7 member 11
increases expression
ISO
Levofloxacin results in increased expression of SLC7A11 mRNA
CTD
PMID:32816093
NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:136,532,246...136,695,695
G
Slco1b2
solute carrier organic anion transporter family member 1B2
decreases activity
ISO
Levofloxacin results in decreased activity of SLCO1B3 protein
CTD
PMID:39023798
NCBI chr 4:176,282,577...176,355,557
Ensembl chr 4:176,282,584...176,351,083
G
Slpi
secretory leukocyte peptidase inhibitor
decreases expression
ISO
Levofloxacin results in decreased expression of SLPI mRNA
CTD
PMID:32816093
NCBI chr 3:173,501,573...173,503,822
Ensembl chr 3:173,501,573...173,503,822
G
Spa17
sperm autoantigenic protein 17
decreases expression
EXP
Levofloxacin results in decreased expression of SPA17 mRNA
CTD
PMID:24136188
NCBI chr 8:45,496,175...45,507,262
Ensembl chr 8:45,496,175...45,507,262
G
Srxn1
sulfiredoxin 1
decreases expression
EXP
Levofloxacin results in decreased expression of SRXN1 mRNA
CTD
PMID:24136188
NCBI chr 3:161,064,812...161,070,372
Ensembl chr 3:161,059,931...161,088,765
G
Ssx2ip
SSX family member 2 interacting protein
decreases expression
EXP
Levofloxacin results in decreased expression of SSX2IP mRNA
CTD
PMID:24136188
NCBI chr 2:237,958,286...237,991,026
Ensembl chr 2:237,958,465...237,991,017
G
Stat3
signal transducer and activator of transcription 3
increases expression
EXP
Levofloxacin results in increased expression of STAT3 mRNA
CTD
PMID:24136188
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359
G
Steap3
STEAP3 metalloreductase
decreases expression
EXP
Levofloxacin results in decreased expression of STEAP3 mRNA
CTD
PMID:24136188
NCBI chr13:33,904,710...33,950,100
Ensembl chr13:33,904,710...33,950,080
G
Stmn1
stathmin 1
decreases expression
EXP
Levofloxacin results in decreased expression of STMN1 mRNA
CTD
PMID:24136188
NCBI chr 5:151,964,308...151,970,843
Ensembl chr 5:151,964,351...151,970,842
G
Sumf1
sulfatase modifying factor 1
increases expression
EXP
Levofloxacin results in increased expression of SUMF1 mRNA
CTD
PMID:24136188
NCBI chr 4:142,634,766...142,716,726
Ensembl chr 4:142,634,767...142,716,712
G
Synrg
synergin, gamma
increases expression
EXP
Levofloxacin results in increased expression of SYNRG mRNA
CTD
PMID:24136188
NCBI chr10:69,346,154...69,428,714
Ensembl chr10:69,322,114...69,428,714
G
Syvn1
synoviolin 1
increases expression
EXP
Levofloxacin results in increased expression of SYVN1 mRNA
CTD
PMID:24136188
NCBI chr 1:212,766,736...212,775,426
Ensembl chr 1:212,768,907...212,776,457
G
Tcirg1
T-cell immune regulator 1, ATPase H+ transporting V0 subunit A3
decreases expression
EXP
Levofloxacin results in decreased expression of TCIRG1 mRNA
CTD
PMID:24136188
NCBI chr 1:210,556,270...210,568,021
Ensembl chr 1:210,556,270...210,568,033
G
Tef
TEF transcription factor, PAR bZIP family member
increases expression
EXP
Levofloxacin results in increased expression of TEF mRNA
CTD
PMID:24136188
NCBI chr 7:115,197,180...115,221,930
Ensembl chr 7:115,193,282...115,221,928
G
Tjp2
tight junction protein 2
decreases expression
EXP
Levofloxacin results in decreased expression of TJP2 mRNA
CTD
PMID:24136188
NCBI chr 1:231,136,218...231,264,750
Ensembl chr 1:231,136,243...231,264,750
G
Tkt
transketolase
decreases expression
EXP
Levofloxacin results in decreased expression of TKT mRNA
CTD
PMID:24136188
NCBI chr16:5,729,381...5,755,170
Ensembl chr16:5,729,991...5,756,431
G
Tmem176b
transmembrane protein 176B
increases expression
EXP
Levofloxacin results in increased expression of TMEM176B mRNA
CTD
PMID:24136188
NCBI chr 4:79,097,808...79,105,263
Ensembl chr 4:79,097,808...79,105,263
G
Tmem38b
transmembrane protein 38B
increases expression
EXP
Levofloxacin results in increased expression of TMEM38B mRNA
CTD
PMID:24136188
NCBI chr 5:73,255,662...73,291,383
Ensembl chr 5:73,255,632...73,292,384
G
Tnf
tumor necrosis factor
multiple interactions
ISO
[Levofloxacin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein; [Levofloxacin co-treated with TNF protein] results in increased expression of ICAM1 protein; [Levofloxacin co-treated with TNF protein] results in increased expression of TNFAIP3 mRNA; [TNF protein co-treated with Levofloxacin] results in increased lipidation of MAP1LC3B protein; TNF protein promotes the reaction [Levofloxacin results in increased expression of MAP1LC3B protein] [Levofloxacin co-treated with TNF protein] results in increased expression of BIRC2 mRNA; [Levofloxacin co-treated with TNF protein] results in increased expression of ICAM1 protein; [Levofloxacin co-treated with TNF protein] results in increased expression of NFKBIA mRNA; [Levofloxacin co-treated with TNF protein] results in increased expression of TNFAIP3 mRNA
CTD
PMID:30876886 PMID:32035082 PMID:33609687
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
G
Tnfaip3
TNF alpha induced protein 3
multiple interactions
ISO
[Levofloxacin co-treated with TNF protein] results in increased expression of TNFAIP3 mRNA
CTD
PMID:32035082
NCBI chr 1:15,528,921...15,543,993
Ensembl chr 1:15,528,921...15,543,979
G
Tnfaip6
TNF alpha induced protein 6
decreases expression
ISO
Levofloxacin results in decreased expression of TNFAIP6 mRNA
CTD
PMID:32816093
NCBI chr 3:56,911,398...56,930,797
Ensembl chr 3:56,911,252...56,930,796
G
Tnfrsf9
TNF receptor superfamily member 9
decreases expression
EXP
Levofloxacin results in decreased expression of TNFRSF9 mRNA
CTD
PMID:24136188
NCBI chr 5:166,664,494...166,690,834
Ensembl chr 5:166,664,494...166,690,831
G
Tob2
transducer of ERBB2, 2
increases expression
EXP
Levofloxacin results in increased expression of TOB2 mRNA
CTD
PMID:24136188
NCBI chr 7:115,242,843...115,251,563
Ensembl chr 7:115,239,895...115,258,155
G
Tpm3
tropomyosin 3
decreases expression
EXP
Levofloxacin results in decreased expression of TPM3 mRNA
CTD
PMID:24136188
NCBI chr 2:177,812,534...177,842,661
Ensembl chr 2:177,814,883...177,842,660
G
Tsc22d3
TSC22 domain family, member 3
increases expression
EXP
Levofloxacin results in increased expression of TSC22D3 mRNA
CTD
PMID:24136188
NCBI chr X:109,006,410...109,066,389
Ensembl chr X:109,006,420...109,015,519
G
Tstd3
thiosulfate sulfurtransferase like domain containing 3
decreases expression
EXP
Levofloxacin results in decreased expression of TSTD3 mRNA
CTD
PMID:24136188
NCBI chr 5:40,091,438...40,101,509
Ensembl chr 5:40,065,807...40,100,878
G
Tuba1c
tubulin, alpha 1C
decreases expression
EXP
Levofloxacin results in decreased expression of TUBA1C mRNA
CTD
PMID:24136188
NCBI chr 7:131,636,974...132,078,589
Ensembl chr 7:132,070,536...132,079,311
G
Tubb4b
tubulin, beta 4B class IVb
decreases expression
EXP
Levofloxacin results in decreased expression of TUBB4B mRNA
CTD
PMID:24136188
NCBI chr 3:28,435,999...28,438,455
Ensembl chr 3:28,435,148...28,439,719
G
Tubb5
tubulin, beta 5 class I
decreases expression
EXP
Levofloxacin results in decreased expression of TUBB5 mRNA
CTD
PMID:24136188
NCBI chr20:2,917,577...2,921,726
Ensembl chr20:2,917,539...2,921,726
G
Tubb6
tubulin, beta 6 class V
decreases expression
EXP
Levofloxacin results in decreased expression of TUBB6 mRNA
CTD
PMID:24136188
NCBI chr18:63,213,287...63,222,926
Ensembl chr18:63,213,279...63,224,303
G
Ugt1a2
UDP glucuronosyltransferase 1 family, polypeptide A2
decreases activity
ISO
Levofloxacin results in decreased activity of UGT1A3 protein
CTD
PMID:39023798
NCBI chr 9:96,239,019...96,256,264
Ensembl chr 9:96,144,786...96,256,264
G
Ugt2b7
UDP glucuronosyltransferase family 2 member B7
decreases activity
ISO
Levofloxacin results in decreased activity of UGT2B7 protein
CTD
PMID:39023798
NCBI chr14:21,251,535...21,274,451
Ensembl chr14:21,251,535...21,274,451
G
Usp2
ubiquitin specific peptidase 2
increases expression
EXP
Levofloxacin results in increased expression of USP2 mRNA
CTD
PMID:24136188
NCBI chr 8:53,308,264...53,336,800
Ensembl chr 8:53,308,303...53,336,794
G
Vcam1
vascular cell adhesion molecule 1
increases expression
EXP
Levofloxacin results in increased expression of VCAM1 mRNA
CTD
PMID:24136188
NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801
G
Vim
vimentin
decreases expression
EXP
Levofloxacin results in decreased expression of VIM mRNA
CTD
PMID:24136188
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:81,568,272...81,585,746
G
Vmp1
vacuole membrane protein 1
increases expression
EXP
Levofloxacin results in increased expression of VMP1 mRNA
CTD
PMID:24136188
NCBI chr10:71,903,223...72,002,337
Ensembl chr10:71,903,227...72,002,319
G
Wasl
WASP like actin nucleation promoting factor
increases expression
EXP
Levofloxacin results in increased expression of WASL mRNA
CTD
PMID:24136188
NCBI chr 4:54,049,081...54,097,653
Ensembl chr 4:54,049,082...54,097,570
G
Wipi1
WD repeat domain, phosphoinositide interacting 1
increases expression
EXP
Levofloxacin results in increased expression of WIPI1 mRNA
CTD
PMID:24136188
NCBI chr10:95,042,451...95,079,679
Ensembl chr10:95,042,441...95,079,293
G
Xpo1
exportin 1
decreases expression
EXP
Levofloxacin results in decreased expression of XPO1 mRNA
CTD
PMID:24136188
NCBI chr14:101,434,450...101,476,705
Ensembl chr14:101,434,517...101,476,714
G
Zfp354a
zinc finger protein 354A
increases expression
EXP
Levofloxacin results in increased expression of ZFP354A mRNA
CTD
PMID:24136188
NCBI chr10:35,897,217...35,909,063
Ensembl chr10:35,897,228...35,909,510
G
Zfp446
zinc finger protein 446
increases expression
EXP
Levofloxacin results in increased expression of ZFP446 mRNA
CTD
PMID:24136188
NCBI chr 1:82,673,920...82,680,414
Ensembl chr 1:82,673,918...82,685,430
G
Abcb11
ATP binding cassette subfamily B member 11
decreases activity multiple interactions
ISO
Ofloxacin results in decreased activity of ABCB11 protein Ofloxacin inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid]
CTD
PMID:24014644
NCBI chr 3:74,424,620...74,520,646
Ensembl chr 3:74,424,979...74,520,581
G
Arhgap45
Rho GTPase activating protein 45
affects expression
ISO
Ofloxacin affects the expression of ARHGAP45 mRNA
CTD
PMID:25811541
NCBI chr 7:10,325,515...10,340,955
Ensembl chr 7:10,325,539...10,341,890
G
Asah1
N-acylsphingosine amidohydrolase 1
increases expression
ISO
Ofloxacin results in increased expression of ASAH1 mRNA
CTD
PMID:17175557
NCBI chr16:57,669,927...57,701,349
Ensembl chr16:57,669,750...57,718,305
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions
ISO
[Ofloxacin co-treated with Clarithromycin] inhibits the reaction [CYP1A2 protein results in increased metabolism of Theophylline]
CTD
PMID:11408986
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions
ISO
[Ofloxacin co-treated with Clarithromycin] inhibits the reaction [CYP3A4 protein results in increased metabolism of Theophylline]
CTD
PMID:11408986
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
G
Depp1
DEPP autophagy regulator 1
increases expression
ISO
Ofloxacin results in increased expression of DEPP1 mRNA
CTD
PMID:17175557
NCBI chr 4:151,583,105...151,585,455
Ensembl chr 4:151,581,502...151,586,233
G
Il1b
interleukin 1 beta
multiple interactions
ISO
Ofloxacin inhibits the reaction [IL1B protein results in increased expression of MMP13 mRNA]
CTD
PMID:16148020
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
G
Ins1
insulin 1
increases expression
EXP
Ofloxacin results in increased expression of INS1 protein
CTD
PMID:17026994
NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682
G
Itgb4
integrin subunit beta 4
decreases expression
ISO
Ofloxacin results in decreased expression of ITGB4 protein
CTD
PMID:14687228
NCBI chr10:101,705,592...101,741,933
Ensembl chr10:101,705,587...101,741,932
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
affects binding
ISO
Ofloxacin binds to KCNH2 protein
CTD
PMID:34058295
NCBI chr 4:11,719,357...11,751,424
Ensembl chr 4:11,692,980...11,751,421
G
Mmp13
matrix metallopeptidase 13
multiple interactions decreases expression
ISO
Ofloxacin inhibits the reaction [IL1B protein results in increased expression of MMP13 mRNA] Ofloxacin results in decreased expression of MMP13 mRNA
CTD
PMID:16148020
NCBI chr 8:12,782,829...12,793,108
Ensembl chr 8:12,782,813...12,793,105
G
Mmp3
matrix metallopeptidase 3
increases expression
EXP
Ofloxacin results in increased expression of MMP3 mRNA
CTD
PMID:20688128
NCBI chr 8:12,925,267...12,938,828
Ensembl chr 8:12,925,280...12,938,826
G
Nupr1
nuclear protein 1, transcriptional regulator
increases expression
ISO
Ofloxacin results in increased expression of NUPR1 mRNA
CTD
PMID:17175557
NCBI chr 1:190,643,866...190,645,901
Ensembl chr 1:190,643,867...190,645,901
G
Pgd
phosphogluconate dehydrogenase
decreases activity
EXP
Ofloxacin results in decreased activity of PGD protein
CTD
PMID:15558954
NCBI chr 5:164,865,830...164,882,029
Ensembl chr 5:164,865,830...164,882,029
G
Phyh
phytanoyl-CoA 2-hydroxylase
decreases expression
ISO
Ofloxacin results in decreased expression of PHYH mRNA
CTD
PMID:15342952
NCBI chr17:78,238,747...78,255,645
Ensembl chr17:78,238,747...78,255,645
G
Plaur
plasminogen activator, urokinase receptor
increases expression
EXP
Ofloxacin results in increased expression of PLAUR mRNA
CTD
PMID:20688128
NCBI chr 1:89,181,363...89,196,308
Ensembl chr 1:89,178,453...89,198,130
G
Ptgs2
prostaglandin-endoperoxide synthase 2
increases expression
EXP
Ofloxacin results in increased expression of PTGS2 mRNA
CTD
PMID:20688128
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
G
RT1-A2
RT1 class Ia, locus A2
affects expression
ISO
Ofloxacin affects the expression of HLA-E mRNA
CTD
PMID:25811541
NCBI chr20:4,872,720...4,876,425
G
Slc22a5
solute carrier family 22 member 5
multiple interactions
ISO EXP
Ofloxacin inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine]
CTD
PMID:16928358
NCBI chr10:38,509,072...38,536,240
Ensembl chr10:38,509,072...38,536,077
G
Slc2a1
solute carrier family 2 member 1
affects localization decreases expression
ISO
Ofloxacin affects the localization of SLC2A1 mRNA Ofloxacin results in decreased expression of SLC2A1 mRNA
CTD
PMID:19022360
NCBI chr 5:138,002,522...138,030,742
Ensembl chr 5:138,002,522...138,030,742
G
Tnfrsf12a
TNF receptor superfamily member 12A
increases expression
EXP
Ofloxacin results in increased expression of TNFRSF12A mRNA
CTD
PMID:20688128
NCBI chr10:13,211,670...13,213,666
Ensembl chr10:13,211,673...13,213,704
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
increases glucuronidation
ISO
UGT1A1 protein results in increased glucuronidation of Ofloxacin
CTD
PMID:15769885
NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:96,144,786...96,256,264
G
Ugt1a2
UDP glucuronosyltransferase 1 family, polypeptide A2
increases glucuronidation
ISO
UGT1A3 protein results in increased glucuronidation of Ofloxacin
CTD
PMID:15769885
NCBI chr 9:96,239,019...96,256,264
Ensembl chr 9:96,144,786...96,256,264
G
Ugt1a9
UDP glucuronosyltransferase family 1 member A9
increases glucuronidation
ISO
UGT1A9 protein results in increased glucuronidation of Ofloxacin
CTD
PMID:15769885
NCBI chr 9:96,144,786...96,256,264
Ensembl chr 9:96,144,786...96,256,264
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all